New nasal spray drug enters first human safety tests
NCT ID NCT07163182
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 29 times
Summary
This early-stage trial is testing a new drug called CHF6467, given as a nasal spray, in 68 healthy adults. The main goal is to see if it is safe and how the body processes it. The study will also check if the drug reaches the fluid around the brain and spinal cord, and whether it triggers an immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bulgaria MC Comac Medical Ltd.
RECRUITINGSofia, 1618, Bulgaria
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CHF6467
What could go wrong
This is an early Phase 1 trial in healthy volunteers, so it does not test any disease treatment. The drug may cause side effects or not work as hoped in future studies.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.